Skip to main content

Botox News (Page 2)

FDA Medwatch Alert: Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B)

FDA notified healthcare professionals that after an ongoing safety review initiated in February 2008, the manufacturers of licensed botulinum toxin products will be required by FDA to strengthen...

FDA Medwatch Alert: Botox, Botox Cosmetic (Botulinum toxin Type A), Myobloc (Botulinum toxin Type B)

[Posted 02/07/2008] FDA issued an early communication about an ongoing safety review regarding Botox and Botox Cosmetic. FDA has received reports of systemic adverse reactions including respiratory...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Cervical Dystonia, Chronic Migraine, Facial Wrinkles, Hyperhidrosis, Migraine, Migraine Prevention, Migraine Prophylaxis, Overactive Bladder, Urinary Incontinence

Botox patient information at Drugs.com